Skip to main content
. 2020 Apr 2;46(4):62–68. doi: 10.14745/ccdr.v46i04a02

Table 1. Vaccine candidate gap analysis.

PHP Provincial/territorial PHPs for RSV RSV vaccine candidate in development to address priority
1 Preventing hospitalization and death in infants Janssen Junior, GSK Maternal and Pediatric, Novavax Maternal, AstraZeneca/Sanofi Pasteura
2 Preventing hospitalization and death in high-risk infants Janssen Juniors, GSK Maternal and Pediatric, Novavax Maternal, AstraZeneca/Sanofi Pasteura
3 Preventing infection in children living in remote settings AstraZeneca/Sanofi Pasteurb
4 Preventing hospitalization and death in children AstraZeneca/Sanofi Pasteura
5 Preventing hospitalization and death in older adults Janssen Senior, GSK Older Adult, Novavax Older Adult, Bavarian Nordica

Abbreviations: PHP, public health priority; RSV, respiratory syncytial virus

a RSV candidate directly addresses public health priority

b RSV candidate partially addresses public health priority